Effect and Safety of Liraglutide 3.0 mg as an Adjunct to Intensive Behaviour Therapy for Obesity in a Non-specialist Setting
Clinical trial NCT02963935 · COMPLETED
Trial details
- NCT number
- NCT02963935
- Sponsor
- Novo Nordisk A/S
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-02-06
- Primary completion
- 2018-05-23
- Enrollment
- 282
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.